Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases. - Dong, Yawen; Tschoegl, Madita; Lehner, Florian; Santol, Jonas; Notte, Francesca; Gramberger, Mariel; Salem, Mohammed; Cenan, Edanur; Thonhauser, Rebecca; Hoblaj, Thomas; Valenta, Rosemarie; Gruenberger, Birgit; et al. (Cancers, 2026)